Target intelligence / Profile preview

SaeRS two-component regulatory system (SaeRS)

Target
SaeRS
Molecular classification
Two-component system, Histidine kinase, Response regulator, Transcription factor, Signal transduction protein
01

Overview

The SaeRS two-component regulatory system is a critical signaling pathway in Staphylococcus aureus that controls the expression of over 20 major virulence factors, including alpha-hemolysin, coagulase, and various immune-evasion proteins (PMID: 21854221, 26150533). It consists of the sensor histidine kinase SaeS, which detects host-derived signals such as alpha-defensins and pH changes, and the response regulator SaeR, which acts as a transcription factor upon phosphorylation (PMID: 17114253). Because SaeRS is essential for the pathogenesis of S. aureus in various infection models, it has become a prominent target for anti-virulence therapy (PMID: 29133444). Inhibiting this system does not necessarily kill the bacteria but renders them less harmful and more susceptible to host immune clearance, potentially reducing the selective pressure for antibiotic resistance (PMID: 31515454). Current research focuses on small molecule inhibitors that disrupt the phosphorylation relay or the DNA-binding capability of SaeR to attenuate staphylococcal toxicity (PMID: 27524331).

Other names
SaeR/S systemS. aureus exoprotein expression systemSaeRS TCSStaphylococcus aureus exoprotein expression regulatory system
02

Mechanism of action

Inhibition of the sensor kinase SaeS autophosphorylation or interference with the DNA-binding activity of the response regulator SaeR to prevent the transcription of virulence genes.

03

Biological functions

Signal transductionRegulation of virulence factor expressionResponse to environmental stimuliBacterial pathogenesisEvasion of host immune response
04

Disease associations

InfectionStaphylococcus aureus infectionBacteremiaSkin and soft tissue infectionPneumonia
05

Safety considerations

Selectivity over human protein kinasesPotential for compensatory mutations in other regulatory systems (e.g., agr)Narrow spectrum of activity (specific to S. aureus)Incomplete clearance of bacteria when used as monotherapy
06

Interacting drugs

Xanthoangelol B

2 more in the full profile.

07

Biomarkers

Alpha-hemolysin (Hla) expression levelsPanton-Valentine leukocidin (PVL) expressionCoagulase activitySaeR phosphorylation state

Beyond the preview

Go deeper on SaeRS two-component regulatory system (SaeRS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SaeRS two-component regulatory system (SaeRS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call